Cargando…

Adenosine in pancreatic cancer: Emerging combination therapies

Detalles Bibliográficos
Autores principales: Roth, Susanne, Hackert, Thilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838397/
https://www.ncbi.nlm.nih.gov/pubmed/31590927
http://dx.doi.org/10.1016/j.ebiom.2019.09.030
_version_ 1783467215182364672
author Roth, Susanne
Hackert, Thilo
author_facet Roth, Susanne
Hackert, Thilo
author_sort Roth, Susanne
collection PubMed
description
format Online
Article
Text
id pubmed-6838397
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-68383972019-11-12 Adenosine in pancreatic cancer: Emerging combination therapies Roth, Susanne Hackert, Thilo EBioMedicine Commentary Elsevier 2019-10-04 /pmc/articles/PMC6838397/ /pubmed/31590927 http://dx.doi.org/10.1016/j.ebiom.2019.09.030 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Roth, Susanne
Hackert, Thilo
Adenosine in pancreatic cancer: Emerging combination therapies
title Adenosine in pancreatic cancer: Emerging combination therapies
title_full Adenosine in pancreatic cancer: Emerging combination therapies
title_fullStr Adenosine in pancreatic cancer: Emerging combination therapies
title_full_unstemmed Adenosine in pancreatic cancer: Emerging combination therapies
title_short Adenosine in pancreatic cancer: Emerging combination therapies
title_sort adenosine in pancreatic cancer: emerging combination therapies
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838397/
https://www.ncbi.nlm.nih.gov/pubmed/31590927
http://dx.doi.org/10.1016/j.ebiom.2019.09.030
work_keys_str_mv AT rothsusanne adenosineinpancreaticcanceremergingcombinationtherapies
AT hackertthilo adenosineinpancreaticcanceremergingcombinationtherapies